Eisai Inc. drugs

7 results
  • fycompa - perampanel tablet

    (Perampanel)
    Eisai Inc.
    Fycompa treats partial-onset seizures with or without secondary generalization in epilepsy patients 4 years and older, and is adjunctive therapy for primary generalized tonic-clonic seizures in epilepsy patients 12 years and older.
  • halaven - eribulin mesylate injection

    (Eribulin Mesylate)
    Eisai Inc.
    HALAVEN treats metastatic breast cancer in patients who have received at least two prior chemotherapy regimens including an anthracycline and taxane, and unresectable or metastatic liposarcoma in patients who have received a prior anthracycline-containing regimen.
  • lenvima - lenvatinib capsule

    (Lenvatinib)
    Eisai Inc.
    LENVIMA treats adults with radioactive iodine-refractory differentiated thyroid cancer, advanced renal cell carcinoma (with pembrolizumab or everolimus), unresectable hepatocellular carcinoma, and advanced endometrial carcinoma (with pembrolizumab) in pMMR or non-MSI-H patients who progressed after prior therapy.